HUE035154T2 - Piridin-4-il származékok - Google Patents
Piridin-4-il származékok Download PDFInfo
- Publication number
- HUE035154T2 HUE035154T2 HUE14715427A HUE14715427A HUE035154T2 HU E035154 T2 HUE035154 T2 HU E035154T2 HU E14715427 A HUE14715427 A HU E14715427A HU E14715427 A HUE14715427 A HU E14715427A HU E035154 T2 HUE035154 T2 HU E035154T2
- Authority
- HU
- Hungary
- Prior art keywords
- ethyl
- salt
- diseases
- hydroxypropyl
- oxadiazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Claims (8)
- Sæabashbii IgdsygöÄk s ï gs < R so J «h - kept-: s/« n-n X ,\-x î k ien ahoi a ?<-.?;> loiben R! jelentése 2-5 szénaten-os alkil- vagy cikiopenltl-esoport; «a R; jelentése <OL'€'BíÖH}<BrNBCQ<B?úl{<3opon; vagy annak sója. ! V \ ! g \p-i.->< η s i Su b v< |x! ue ta. » f-t ! ! 'f<< Ί > p .. ni ! u > oh i<t;et í >.? î ' \ V' . *t X£H ' χ ‘ x ' t ’- ! ,!'! Ά sO\
- 3. Egy 1. igéoyporti szerinti vegyölét, ahol R' jelentése b-propd-, Izopropíi-, igobatE-, vagy eiklöpethli-esoperi, vagy annak sóiá.
- 4. Égy 1, igénypoái szerinti vegv^lek ahol E! jelentése elií lopeotlhcsopoh, vagy annak só>·
- 5. Egy 1-4. igénypontok bármelyike szerinti vegyi! let. ahol az -OCH,'C'lKOH)-CH?.'blKCO~CHíOl-5-csn{:ort jeientésö SV sätsreoeenvarns É-feonfignráoíójö, vagy annak sója. ó- Egy 1. igénypont szerinti vegyidét az alábbiak alleotta. csoportból választva: ί$)-Μ-(3-(2-®41~44ό-(2-οίϋρόί!Ϊίΐ>4-ϋ)-1.2,4-ο:κη4ΐΒζο1-3-Ιΐ4ό-Γηε41-ίόηοχί)-24»θΓθχ1ρΓορ11)-ζ·> Indrosiacetamid:. tS)-1443-t2-eili-4-f5--t2-pt6piipifidln-4-!l)-Lz4-oxadiazoS-3-ii)"6-n5etil'-fenoxi)-2-h;di'oxipropil)-2- Indroxiacetsood; ,\x \ '('· - -í o eeo! Ό « nőin -hi' ι'λιϊλΙ 1 ihx' v u x\' : á o\>, u',* ) 2 hidroyiaoctamid; «M-N-t.h{ ?-enl-t-i5'i?-bnolp!i'.3in"!'ih- t^4-ev3duznl-VdVb'nsetnteno\n'3-!iidros!P’Opdb3' hid on .·< : aoe · ám id ; tS)-N-(5-Í2“eSii-4-(S-i2-iztsbsáilgibóisi-é-11)-1 (;-k4-s>x3di;sz.ísi-5-sl!-5-!riebiféirox!5-2-hidrsaí<:igrop'd)-2-h-tdromeetarnkk (S>N-(3'-(2-efil-4-(3-(2-iZi'îpersb;pirâdÎ4'-4-i|fol,2>4-oxgàig:zoi'-3-5Î)-b"Snsïti1féOôXs)-2-biàs’ôxipfiipb)-3“ bifossfoaeeiasfod; (b)-1443-(2-etil-4-(3-(2-(gestáiy3 --4>(>Äi44~bH A4^XtttSaxbi«3éliHvmgtlifénbXí>24ÜáKtxi}>fópíl>'2-·» bsdroxiaeetstniid; és (8)-(4-(3-(2-ίΐϋ-4-(5-(2-éÎS{isjpeôtîÎp5?sd;8-4-îlVh2:s4-oxiîdiaKô;-3-sh-6'-5ï5çtHfti}îoxy-24iidroxîpiOpsn'-2- hldroxlacetamid; vagy ezen '/egyOäetel s<Oi<ä ? Egy 1. îgénypor»! szerinti vegyülsîf, amely {S}-N-{3<2«eiiM-{5'(2<lk)epeot}lplrldi«-4-il)-)/M’öK8djazel-3. lí)'ó-íneísífenosi)<:-h)droxípropll)-2'hidtoxlacetanísd vagy asrnak sója. x '-s' X <-pon χ , it.· 3 5kb ρ,.\ 4 t* " eié' o>. ' - a 1 /·. > :netb'ie8exi)-2-b.idi'oxípir)pií)-2-hídiOXÍiteóta5nsd vagy ssanak sbps.
- 8. Bgy .1-8, igénypontok bármelyiké széria ti vegytÉetét, vagy amtak gyógyászslilag elfogadható sálát, és egy gyégyáMstilsg·. elfogadható hóftfosóáhyágét tartalmazó gyógyászán tazípszzkdó. 1-gy i -2 5gei5\powb hatan, b (ke szénát, vegyidet, vagy aaoak gyógyászatiiag elfogadható sója, vagy egy 9. .-nn.onm, »zurut gxozs ϊ>,<ο, kcnpx x,o nogs,, , < ,> d»,<sfo!<x tsta
- 11. Egy i-§, igénypontok bármelyike szerinti vegyöfot, vagy arnsstk gyógyásgatilág «l&gááháfo spps, aktíváit immusifeadszerrel öss.zeftlggó betegségek vagy rendellenességek megelőzésében vagy kezelésében való alkahn-azasre,
- 12. Egy 1-8. Igénypontok bármelyike szerinti vágyóiét vagy annak gyógyászai slag elfogadható sója. az alábbiak c'k'\\! evopojtbvl s ik>>>n 4 éexipegek r y,y x wik-tsc-sstes.l- ungdb <s.Jx.s rat? -v.-ele-ebs'o '.do alkalmazásra: rtanszplantáll szervek, például vese, máj, szív. tüdő, hasnyálmirigy, szasuhártya és bor fehökóíléss; óssejtálöltetós okozta graft-versas-host betegségek; autolinnsun betegségek, beleértve a. reuatatoid arídtszt sj, "<oss sts slt!5''e\.l gv! .sóssex be h<î<g.ej,.'k t met r <?5ohts betevőt' e- r <obh- uwim r ,\'ΐ·ν.’> ps/o)!4'!M)v ortnlnzt. pat'sm n.n gwlktdost m.n. a Hasban^ti tb\?e“isttti\ es uwo-tetnr szt nopa betegségek trunf a rinilisz, kötőhárrya-gynlhtdás. és atóplás. dermaiítísz; asztma; l-es íiposú diabétesz; fertőzést \'>.e> - 'ss.os 'srs > beí.^e ,es ; e s e fu - resist χ la~»t es , uv v vi'u't > e-e -»ictn îs,î es <. äs 1 s kos és tumor áttét..
- 13. Egy 1-8. Igénypontok bármelyike szériád vegyidet, vagy unnak gyógyászai dag el fogadható sója, az alábbiak ,il\et?a s'^'pci'b'í <5 a-'·..:;, yv!egse;,rk sutó·» .'i«'ss<gel, tcegsfo'ese'xn \ x;\ ke , t( >,foes' s,k> ,<1sî‘îi'.'< s, s'se '"η sz\es'tdc »ótrboív, aszckte's par?<ksfx \o‘ ssiokxk'se /-. , p no setes - x. graft-versus-bost betegségek; renntaloid ssiiritssz, szklerözls multiplex, psxoriázls, pszoriázisos srtrilisz, Crohn» betegség és Hashimoto thyreoidstis kóréból választod autoimmun betegségek; és atópiás demsatífisz.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13159482 | 2013-03-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE035154T2 true HUE035154T2 (hu) | 2018-05-02 |
Family
ID=47877933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE14715427A HUE035154T2 (hu) | 2013-03-15 | 2014-03-14 | Piridin-4-il származékok |
Country Status (34)
Country | Link |
---|---|
US (1) | US9617250B2 (hu) |
EP (1) | EP2970236B1 (hu) |
JP (1) | JP6387361B2 (hu) |
KR (1) | KR102212975B1 (hu) |
CN (1) | CN105189487B (hu) |
AR (1) | AR095523A1 (hu) |
AU (1) | AU2014229217B2 (hu) |
BR (1) | BR112015023161B1 (hu) |
CA (1) | CA2900910C (hu) |
CL (1) | CL2015002620A1 (hu) |
CY (1) | CY1119619T1 (hu) |
DK (1) | DK2970236T3 (hu) |
EA (1) | EA029309B1 (hu) |
ES (1) | ES2649475T3 (hu) |
HK (1) | HK1220454A1 (hu) |
HR (1) | HRP20171763T1 (hu) |
HU (1) | HUE035154T2 (hu) |
IL (1) | IL241363B (hu) |
LT (1) | LT2970236T (hu) |
MA (1) | MA38482B1 (hu) |
MX (1) | MX363545B (hu) |
MY (1) | MY173573A (hu) |
NO (1) | NO2970236T3 (hu) |
NZ (1) | NZ713080A (hu) |
PH (1) | PH12015502118B1 (hu) |
PL (1) | PL2970236T3 (hu) |
PT (1) | PT2970236T (hu) |
SA (1) | SA515361104B1 (hu) |
SG (1) | SG11201507227UA (hu) |
SI (1) | SI2970236T1 (hu) |
TW (1) | TWI623534B (hu) |
UA (1) | UA115357C2 (hu) |
WO (1) | WO2014141171A1 (hu) |
ZA (1) | ZA201507657B (hu) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014110574A1 (en) | 2013-01-14 | 2014-07-17 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors |
ME03780B (me) | 2013-01-15 | 2021-04-20 | Incyte Holdings Corp | Jedinjenja tiazolkarboksamida i piridinkarboksamida korisna kao inhibitori pim kinaze |
PE20160532A1 (es) | 2013-08-23 | 2016-05-21 | Incyte Corp | Compuesto de carboxamida de furo y tienopiridina utiles como inhibidores de cinasas pim |
WO2016010897A1 (en) | 2014-07-14 | 2016-01-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors |
US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
HUE047646T2 (hu) | 2015-05-20 | 2020-05-28 | Idorsia Pharmaceuticals Ltd | Az (S)-3-{4-[5-(2-ciklopentil-6-metoxi-piridin-4-il)-[1,2,4]oxadiazol-3-il]-2-etil-6-metil-fenoxi} -propán-1,2-diol vegyület kristályformája |
US9540347B2 (en) | 2015-05-29 | 2017-01-10 | Incyte Corporation | Pyridineamine compounds useful as Pim kinase inhibitors |
WO2017004610A1 (en) * | 2015-07-02 | 2017-01-05 | Exelixis, Inc. | Tercyclic s1p3-sparing, s1p1 receptor agonists |
TWI734699B (zh) | 2015-09-09 | 2021-08-01 | 美商英塞特公司 | Pim激酶抑制劑之鹽 |
TW201718546A (zh) | 2015-10-02 | 2017-06-01 | 英塞特公司 | 適用作pim激酶抑制劑之雜環化合物 |
WO2019113487A1 (en) | 2017-12-08 | 2019-06-13 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7686891A (en) | 1990-04-05 | 1991-10-30 | American National Red Cross, The | A protein family related to immediate-early protein expressed by human endothelial cells during differentiation |
US6423508B1 (en) | 1998-03-09 | 2002-07-23 | Smithkline Beecham Corporation | Polynucleotide sequences of human EDG-1c |
WO2004035538A1 (en) | 2002-10-15 | 2004-04-29 | Merck & Co., Inc. | Process for making azetidine-3-carboxylic acid |
TWI392671B (zh) | 2006-09-07 | 2013-04-11 | Actelion Pharmaceuticals Ltd | 吡啶-4-基衍生物 |
PL2069335T3 (pl) | 2006-09-08 | 2013-05-31 | Actelion Pharmaceuticals Ltd | Pochodne pirydyn-3-ylu jako środki immunomodulujące |
ES2393412T3 (es) | 2006-09-21 | 2012-12-21 | Actelion Pharmaceuticals Ltd. | Derivados de fenilo y su uso como inmunomoduladores |
DK2125797T3 (da) | 2007-03-16 | 2014-02-10 | Actelion Pharmaceuticals Ltd | Aminopyridinderivater som s1p1/edg1-receptoragonister |
WO2009024905A1 (en) | 2007-08-17 | 2009-02-26 | Actelion Pharmaceuticals Ltd | Pyridine derivatives as s1p1/edg1 receptor modulators |
EA201070422A1 (ru) | 2007-10-04 | 2010-12-30 | Мерк Сероно С.А. | Производные оксадиазола |
AU2008320374A1 (en) | 2007-11-01 | 2009-05-07 | Actelion Pharmaceuticals Ltd | Novel pyrimidine derivatives |
WO2009109907A1 (en) | 2008-03-06 | 2009-09-11 | Actelion Pharmaceuticals Ltd | Novel pyrimidine-pyridine derivatives |
JP5411877B2 (ja) | 2008-03-06 | 2014-02-12 | アクテリオン ファーマシューティカルズ リミテッド | ピリジン化合物 |
EP2262782B1 (en) | 2008-03-07 | 2012-07-04 | Actelion Pharmaceuticals Ltd. | Novel aminomethyl benzene derivatives |
KR101615779B1 (ko) | 2008-03-07 | 2016-04-26 | 액테리온 파마슈티칼 리미티드 | 면역조절제로서 피리딘-2-일 유도체 |
PT2291080E (pt) * | 2008-05-14 | 2015-10-30 | Scripps Research Inst | Novos modelamodeladores dos recetores da esfingosina fosfato |
ES2517265T3 (es) | 2009-03-03 | 2014-11-03 | Merck Serono S.A. | Derivados de oxadiazol piridina |
RU2547098C2 (ru) | 2009-07-16 | 2015-04-10 | Актелион Фармасьютиклз Лтд | Производные пиридин-4-ила |
TW201120016A (en) | 2009-12-08 | 2011-06-16 | Abbott Lab | Novel oxadiazole compounds |
WO2012098505A1 (en) | 2011-01-19 | 2012-07-26 | Actelion Pharmaceuticals Ltd | 2-methoxy-pyridin-4-yl derivatives |
-
2014
- 2014-03-14 NZ NZ713080A patent/NZ713080A/en unknown
- 2014-03-14 BR BR112015023161-6A patent/BR112015023161B1/pt active IP Right Grant
- 2014-03-14 MY MYPI2015703154A patent/MY173573A/en unknown
- 2014-03-14 WO PCT/IB2014/059794 patent/WO2014141171A1/en active Application Filing
- 2014-03-14 ES ES14715427.2T patent/ES2649475T3/es active Active
- 2014-03-14 SI SI201430428T patent/SI2970236T1/sl unknown
- 2014-03-14 PT PT147154272T patent/PT2970236T/pt unknown
- 2014-03-14 AR ARP140101131A patent/AR095523A1/es active IP Right Grant
- 2014-03-14 KR KR1020157028486A patent/KR102212975B1/ko active IP Right Grant
- 2014-03-14 CA CA2900910A patent/CA2900910C/en active Active
- 2014-03-14 TW TW103109288A patent/TWI623534B/zh active
- 2014-03-14 JP JP2015562523A patent/JP6387361B2/ja active Active
- 2014-03-14 EP EP14715427.2A patent/EP2970236B1/en active Active
- 2014-03-14 EA EA201500931A patent/EA029309B1/ru not_active IP Right Cessation
- 2014-03-14 NO NO14715427A patent/NO2970236T3/no unknown
- 2014-03-14 US US14/777,444 patent/US9617250B2/en active Active
- 2014-03-14 HU HUE14715427A patent/HUE035154T2/hu unknown
- 2014-03-14 LT LTEP14715427.2T patent/LT2970236T/lt unknown
- 2014-03-14 MA MA38482A patent/MA38482B1/fr unknown
- 2014-03-14 PL PL14715427T patent/PL2970236T3/pl unknown
- 2014-03-14 AU AU2014229217A patent/AU2014229217B2/en not_active Ceased
- 2014-03-14 SG SG11201507227UA patent/SG11201507227UA/en unknown
- 2014-03-14 MX MX2015012293A patent/MX363545B/es unknown
- 2014-03-14 DK DK14715427.2T patent/DK2970236T3/en active
- 2014-03-14 UA UAA201510003A patent/UA115357C2/uk unknown
- 2014-03-14 CN CN201480016238.1A patent/CN105189487B/zh active Active
-
2015
- 2015-09-09 IL IL241363A patent/IL241363B/en active IP Right Grant
- 2015-09-11 CL CL2015002620A patent/CL2015002620A1/es unknown
- 2015-09-14 SA SA515361104A patent/SA515361104B1/ar unknown
- 2015-09-14 PH PH12015502118A patent/PH12015502118B1/en unknown
- 2015-10-14 ZA ZA2015/07657A patent/ZA201507657B/en unknown
-
2016
- 2016-07-18 HK HK16108473.1A patent/HK1220454A1/zh not_active IP Right Cessation
-
2017
- 2017-11-15 HR HRP20171763TT patent/HRP20171763T1/hr unknown
- 2017-11-24 CY CY20171101239T patent/CY1119619T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2970236T3 (en) | Pyridin-4-yl derivatives | |
US8658675B2 (en) | Pyridin-4-yl derivatives | |
CA2661315C (en) | Pyridin-3-yl derivatives as immunomodulating agents | |
WO2005123677A1 (en) | 4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents | |
CA2715437C (en) | Pyridin-2-yl derivatives as immunomodulating agents | |
EP2262800A1 (en) | Novel pyrimidine-pyridine derivatives |